SPML Infra bags Rs 258 crore water infrastructure project from Chennai Metropolitan Water Supply
SPML Infra Limited (NSE: SPMLINFRA, BSE: 500402), a publicly listed infrastructure company, has received a Letter of Acceptance (LoA) for a new water infrastructure project valued at Rs. 258 crore. The project has been awarded by the Chennai Metropolitan Water Supply and Sewerage Board (CMWSSB) to a consortium of SPML Infra Limited (26% share) and JWIL Infra Limited (74%).
The project is aimed at enhancing water supply infrastructure in the Chennai region, with a primary focus on the construction, testing, and commissioning of a new water reservoir at Porur. This facility is designed to improve water storage capacity in the city.
Additional components of the project include the development of a new pumping station and associated infrastructure to support water transfer and distribution. The supporting works will be primarily carried out in the Porur and Perur areas of Chennai.
An integral part of the project is its long-term Operation and Maintenance (O&M) contract. The consortium will manage and maintain the infrastructure for a period of 20 years, ensuring continued operational efficiency.
This development contributes to ongoing efforts to improve urban water infrastructure in Chennai.
Aman Shukla is a post-graduate in mass communication . A media enthusiast who has a strong hold on communication ,content writing and copy writing. Aman is currently working as journalist at BusinessUpturn.com
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Upturn
11 hours ago
- Business Upturn
Zydus Lifesciences gets USFDA nod for Prucalopride tablets, 1 mg and 2 mg
Zydus Lifesciences Limited has received final approval from the US Food and Drug Administration (USFDA) to market Prucalopride Tablets, 1 mg and 2 mg (reference listed drug: Motegrity® ). The tablets are indicated for the treatment of chronic idiopathic constipation (CIC) — a condition in which the cause of constipation is unknown and persistent. Prucalopride works by stimulating natural peristalsis in the colon, thereby aiding regular bowel movements. With this approval, Zydus adds another feather to its cap in the US generics market. The approved tablets will be manufactured at the company's SEZ facility in Ahmedabad, Gujarat. According to IQVIA MAT data for June 2025, Prucalopride tablets had annual sales of USD 186.8 million in the US market. This approval strengthens Zydus' position in the gastrointestinal segment and adds to its growing US portfolio. With this latest nod, the group has now received 422 approvals since it began filing ANDAs (Abbreviated New Drug Applications) in FY 2003-04. In total, Zydus has filed 483 ANDAs so far. Ahmedabad Plane Crash Aman Shukla is a post-graduate in mass communication . A media enthusiast who has a strong hold on communication ,content writing and copy writing. Aman is currently working as journalist at
Business Upturn
11 hours ago
- Business Upturn
Cabinet approves Rs 30,000 crore compensation for PSU oil companies' LPG losses
By Aditya Bhagchandani Published on August 8, 2025, 16:36 IST The Union Cabinet, chaired by Prime Minister Narendra Modi, has approved Rs 30,000 crore in compensation to three public sector oil marketing companies — Indian Oil Corporation (IOCL), Bharat Petroleum Corporation (BPCL) and Hindustan Petroleum Corporation (HPCL) — for losses incurred on domestic LPG sales. The amount will be distributed by the Ministry of Petroleum and Natural Gas in twelve tranches. Domestic LPG cylinders are supplied at regulated prices by these OMCs. With international LPG prices remaining elevated through 2024-25, the companies absorbed the cost increase without passing it on to consumers, resulting in substantial under-recoveries. Despite these losses, supply of domestic LPG was maintained across the country. The approved compensation will help the OMCs meet key needs, including crude and LPG procurement, debt servicing and capital expenditure, ensuring uninterrupted LPG availability. The move also reinforces the government's commitment to protect consumers from global price volatility and maintain access to clean cooking fuel under schemes such as the Pradhan Mantri Ujjwala Yojana. Ahmedabad Plane Crash Aditya Bhagchandani serves as the Senior Editor and Writer at Business Upturn, where he leads coverage across the Business, Finance, Corporate, and Stock Market segments. With a keen eye for detail and a commitment to journalistic integrity, he not only contributes insightful articles but also oversees editorial direction for the reporting team.
Business Upturn
11 hours ago
- Business Upturn
Dr. Reddy's Laboratorie gets EIR from USFDA for Telangana facility with VAI status
By Aman Shukla Published on August 8, 2025, 16:24 IST Dr. Reddy's Laboratories has received the Establishment Inspection Report (EIR) from the US Food and Drug Administration (USFDA) for its API manufacturing facility (CTO 5) in Miryalaguda, Telangana. The EIR was issued on August 7, 2025, following a GMP inspection that was earlier conducted and disclosed by the company on May 24, 2025. The USFDA has classified the outcome of the inspection as 'Voluntary Action Indicated (VAI)' , meaning the agency has closed the inspection with some observations, but no further regulatory action is anticipated at this time. The inspection is officially considered closed under 21 CFR 20.64(d)(3). A VAI classification typically indicates that the facility remains compliant for continued supply to the US market. This update should bring some regulatory clarity and comfort to stakeholders and investors. Ahmedabad Plane Crash Aman Shukla is a post-graduate in mass communication . A media enthusiast who has a strong hold on communication ,content writing and copy writing. Aman is currently working as journalist at
